CSRP3 and myocardial infarction: AT1a receptor-deficient mice showed less severe cardiac dysfunction induced by myocardial infarction [29], administration of cardiotoxic agent doxorubicin [30], or genetic disruption of muscle LIM protein (MLP) [31].